All You Need to Know About Adial Pharmaceuticals, Inc. (ADIL) Rating Upgrade to BuyZacks Investment Research • 10/30/23
Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader WebinarGlobeNewsWire • 10/25/23
Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 10/24/23
Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 10/20/23
Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25thAccesswire • 10/19/23
Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug DependenceGlobeNewsWire • 10/19/23
Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership AwardGlobeNewsWire • 10/18/23
Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use DisorderGlobeNewsWire • 09/28/23
Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 09/05/23
Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on AlcoholismGlobeNewsWire • 08/28/23
Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 08/21/23
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement and Reduce the Public FloatGlobeNewsWire • 08/04/23
Adial Provides Business Update Following Favorable Comments from US and EU Regulatory MeetingsGlobeNewsWire • 07/11/23
Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9thGlobeNewsWire • 06/01/23
Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/12/23
Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate's Assets and BusinessGlobeNewsWire • 05/10/23
Is Adial Pharmaceuticals (ADIL) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 04/04/23
Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business UpdateGlobeNewsWire • 03/30/23
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use DisorderGlobeNewsWire • 03/21/23
Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14thGlobeNewsWire • 03/08/23
Adial Pharmaceuticals Provides Update on Regulatory Strategy for AD04 for Treatment of Alcohol Use DisorderGlobeNewsWire • 03/06/23